PLENVU FDA approval date

The FDA approved PLENVU on 4 May 2018.

FDA approval date
4 May 2018

Drug identity has not yet been verified against registry records

Also recorded as ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2018-05-04DayPLENVUFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA209381", "applicant_as_listed_by_fda": "NORGINE", "brand_names": ["PLENVU"], "active_ingredients": ["ASCORBIC ACID", "POLYETHYLENE GLYCOL 3350", "POTASSIUM CHLORIDE", "SODIUM ASCORBATE", "SODIUM CHLORIDE", "SODIUM SULFATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20180504", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026